These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24130282)

  • 1. Use of ASA after warfarin for unprovoked VTE.
    Allan GM; Banh HL; Ference J
    Can Fam Physician; 2013 Oct; 59(10):1075. PubMed ID: 24130282
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin in the secondary prevention of unprovoked thromboembolism: the WARFASA and ASPIRE studies.
    Birocchi S; Scannella E; Ferrari L; Podda GM;
    Intern Emerg Med; 2013 Dec; 8(8):757-60. PubMed ID: 23744554
    [No Abstract]   [Full Text] [Related]  

  • 3. Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin
    Goel R; Fleischman AN; Tan T; Sterbis E; Huang R; Higuera C; Parvizi J; Rothman RH
    Bone Joint J; 2018 Jan; 100-B(1 Supple A):68-75. PubMed ID: 29292343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACP Journal Club: after initial anticoagulation for a first unprovoked venous thromboembolism, aspirin reduced recurrence.
    Dunn A
    Ann Intern Med; 2015 Feb; 162(4):JC5. PubMed ID: 25686192
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
    Prandoni P; Barbar S; Milan M; Vedovetto V; Pesavento R
    Eur J Intern Med; 2014 Jan; 25(1):25-30. PubMed ID: 24120221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
    Robertson L; Yeoh SE; Ramli A
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin Is as Effective as and Safer Than Warfarin for Patients at Higher Risk of Venous Thromboembolism Undergoing Total Joint Arthroplasty.
    Huang RC; Parvizi J; Hozack WJ; Chen AF; Austin MS
    J Arthroplasty; 2016 Sep; 31(9 Suppl):83-6. PubMed ID: 27094242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of Aspirin as a Prophylaxis Agent Against Venous Thromboembolism Results in Lower Incidence of Periprosthetic Joint Infection.
    Huang R; Buckley PS; Scott B; Parvizi J; Purtill JJ
    J Arthroplasty; 2015 Sep; 30(9 Suppl):39-41. PubMed ID: 26182982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?
    Bala A; Huddleston JI; Goodman SB; Maloney WJ; Amanatullah DF
    Clin Orthop Relat Res; 2017 Sep; 475(9):2205-2213. PubMed ID: 28569372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
    Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
    J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspirin for secondary prevention of venous thromboembolism. WARFASA: far from being conclusive].
    Delluc A; Lacut K; Mottier D
    Rev Med Interne; 2013 Feb; 34(2):69-72. PubMed ID: 23154111
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
    JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin for prevention and treatment of venous thromboembolism.
    Becattini C; Agnelli G
    Blood Rev; 2014 May; 28(3):103-8. PubMed ID: 24745726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin, aspirin, and intracranial vascular disease.
    Koroshetz WJ
    N Engl J Med; 2005 Mar; 352(13):1368-70. PubMed ID: 15800233
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of idiopathic venous thromboembolism.
    Cosmi B
    Expert Rev Cardiovasc Ther; 2016 Dec; 14(12):1371-1384. PubMed ID: 27740860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin and recurrent venous thromboembolism.
    Prandoni P; Noventa F; Milan M
    Phlebology; 2013 Mar; 28 Suppl 1():99-104. PubMed ID: 23482543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effective prophylaxis against venous thromboembolism after total joint arthroplasty: warfarin versus aspirin.
    Mostafavi Tabatabaee R; Rasouli MR; Maltenfort MG; Parvizi J
    J Arthroplasty; 2015 Feb; 30(2):159-64. PubMed ID: 25534862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.